Salmeterol + Fluticasone Inhaler Exporter from India | Cordium Pharmaceuticals Pvt Ltd

Salmeterol + Fluticasone Inhaler – Global Respiratory Care Solution
Cordium Pharmaceuticals Pvt Ltd is a leading pharmaceutical exporter from India supplying high-quality Salmeterol + Fluticasone Inhalers to hospitals, respiratory clinics, pharmacies, distributors, and healthcare procurement companies across the United States, United Kingdom, UAE, South Africa, Kenya, Vietnam, and Singapore.
For Export Enquiries:
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Product Composition
Salmeterol Xinafoate + Fluticasone Propionate Inhaler
Common strengths:
Salmeterol 25 mcg + Fluticasone 50 mcg
Salmeterol 25 mcg + Fluticasone 125 mcg
Salmeterol 25 mcg + Fluticasone 250 mcg
Therapeutic Category: Anti-Asthmatic / COPD Management
Dosage Form: Metered Dose Inhaler (MDI)
Storage: Store below 30°C. Protect from direct sunlight and moisture.
Pharmacodynamics of Salmeterol + Fluticasone Inhaler
Salmeterol is a long-acting beta2-adrenergic agonist (LABA) that relaxes bronchial smooth muscles, resulting in prolonged bronchodilation for up to 12 hours.
Fluticasone Propionate is a potent inhaled corticosteroid that reduces airway inflammation, suppresses inflammatory mediators, and decreases mucus production.
Combined Action:
Long-lasting bronchodilation
Reduced airway inflammation
Improved lung function
Reduced frequency of asthma attacks
Better COPD symptom control
Enhanced respiratory quality of life
Pharmacokinetics
Salmeterol
Rapid pulmonary absorption after inhalation
Low systemic bioavailability
Extensive hepatic metabolism
Predominantly metabolized by CYP3A4 pathway
Eliminated mainly through feces
Fluticasone Propionate
Absorbed through lungs after inhalation
High first-pass hepatic metabolism
Minimal oral bioavailability
Strong anti-inflammatory action in respiratory tissues
Eliminated through fecal excretion
Treatment Applications
Asthma Management
Persistent Asthma
Moderate to Severe Asthma
Night-time Asthma Symptoms
Exercise-Induced Bronchospasm Prevention
COPD Management
Chronic Bronchitis
Chronic Airflow Limitation
Emphysema
Long-Term COPD Maintenance Therapy
High-Demand Export Markets & Cities
United States
Major demand cities:
New York
Los Angeles
Chicago
Houston
Miami
Dallas
United Kingdom
Major demand cities:
London
Birmingham
Manchester
Liverpool
Leeds
Glasgow
United Arab Emirates
Major demand cities:
Dubai
Abu Dhabi
Sharjah
Ajman
Al Ain
South Africa
Major demand cities:
Johannesburg
Cape Town
Durban
Pretoria
Port Elizabeth
Kenya
Major demand cities:
Nairobi
Mombasa
Kisumu
Nakuru
Vietnam
Major demand cities:
Ho Chi Minh City
Hanoi
Da Nang
Hai Phong
Singapore
Major demand areas:
Central Singapore
Jurong
Woodlands
Tampines
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Reliable pharmaceutical exporter from India
Competitive international pricing
Fast documentation support
Bulk export supply capability
Timely global delivery
Hospital and distributor supply programs
Quality-focused manufacturing network
Global Supply Coverage
Cordium Pharmaceuticals Pvt Ltd exports respiratory care products to hospitals, wholesalers, pharmacies, government tenders, and healthcare distributors across North America, Europe, Middle East, Africa, and Southeast Asia.
For quotations, distributor opportunities, and bulk procurement:
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
Cordium Pharmaceuticals Pvt Ltd – Trusted Global Partner for Salmeterol + Fluticasone Inhaler Exports from India.